CYTOKINETICS INC — Director's Dealing 2023

Mar 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-03-06

Reporting Person: Jaw Ching (SVP Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-06	Common Stock	A	30000	—	Acquired	87346	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-06	Incentive Stock Option (Right to Buy)	$39.13	A	2555	Acquired	2033-03-06	Common Stock (2555)	Direct
2023-03-06	Non-Qualified Stock Option (Right to Buy)	$39.13	A	47445	Acquired	2033-03-06	Common Stock (47445)	Direct

Footnotes

F1: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.

F2: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.